225 related articles for article (PubMed ID: 10226679)
1. Development of immunoglobulins to venoms during specific immunotherapy.
Palma-Carlos ML; Santos MC; Pedro E; Branco-Ferreira M; Spínola A; Palma-Carlos AG
Allerg Immunol (Paris); 1999 Mar; 31(3):71-2. PubMed ID: 10226679
[TBL] [Abstract][Full Text] [Related]
2. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
3. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
[TBL] [Abstract][Full Text] [Related]
4. [Value of specific IgE and IgG4 measurements in the follow-up of a hymenoptera venom immunotherapy treatment: apropos of 82 cases].
Sonneville A; Loustanau O; Tahar HA; Menelet I
Allerg Immunol (Paris); 2000 Jan; 32(1):20-5. PubMed ID: 10723532
[TBL] [Abstract][Full Text] [Related]
5. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
6. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
Roll A; Hofbauer G; Ballmer-Weber BK; Schmid-Grendelmeier P
J Investig Allergol Clin Immunol; 2006; 16(2):79-85. PubMed ID: 16689180
[TBL] [Abstract][Full Text] [Related]
7. [Evolution of in vivo and in vitro tests during specific immunotherapy against hymenoptera venoms].
Sabbah A; Heulin MG; Soulière I
Allerg Immunol (Paris); 1990 Jun; 22(6):242-7. PubMed ID: 1696102
[TBL] [Abstract][Full Text] [Related]
8. Humoral immunological response in patients with venom allergy during specific immunotherapy.
Szymański W; Chyrek-Borowska S
Rocz Akad Med Bialymst; 1995; 40(2):376-82. PubMed ID: 8834621
[TBL] [Abstract][Full Text] [Related]
9. Development of new IgE specificities to hymenoptera allergens during venom-specific immunotherapy.
Tavares B; Rordigues F; Pereira C; Loureiro G; Chieira C
Eur Ann Allergy Clin Immunol; 2005 May; 37(5):171-6. PubMed ID: 15984315
[TBL] [Abstract][Full Text] [Related]
10. [Immunologic studies in allergic children].
Urbanek R
Fortschr Med; 1981 Sep; 99(34):1367-9. PubMed ID: 7286882
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy against hymenoptera venom: report of ten patients].
Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
[TBL] [Abstract][Full Text] [Related]
12. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
[TBL] [Abstract][Full Text] [Related]
13. [Hypersensitivity to honey bee venom].
Adamek-Guzik T
Przegl Lek; 1994; 51(4):161-6. PubMed ID: 8058985
[TBL] [Abstract][Full Text] [Related]
14. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
Ameno S; Ameno K; Fuke C; Shinohara T; Kiriu T; Kinoshita H; Ijiri I
Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683
[TBL] [Abstract][Full Text] [Related]
15. The frequency and clinical significance of specific IgE to both wasp (Vespula) and honey-bee (Apis) venoms in the same patient.
Egner W; Ward C; Brown DL; Ewan PW
Clin Exp Allergy; 1998 Jan; 28(1):26-34. PubMed ID: 9537776
[TBL] [Abstract][Full Text] [Related]
16. Long-term IgG4 determinations in hymenoptera-sensitive treated patients.
Gentlesk MJ; Halpern GM; Mansmann HC
Ann Allergy; 1987 Oct; 59(4):267-72. PubMed ID: 3662129
[TBL] [Abstract][Full Text] [Related]
17. Honey bee venom specific immunoglobulin G4 in honey bee sting allergic patients and bee keepers.
Cheung NK; Blessing-Moore J; Reid MJ; Yang G
Ann Allergy; 1983 Mar; 50(3):155-60. PubMed ID: 6600888
[TBL] [Abstract][Full Text] [Related]
18. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.
Ebo DG; Hagendorens MM; Schuerwegh AJ; Beirens LM; Bridts CH; De Clerck LS; Stevens WJ
Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and biological surveillance after the cessation of Hymenoptera venom desensitization].
Touraine F; Talayrach D; Florea O; Brianchon Ch; Preux PM; Bonnaud F
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):335-9. PubMed ID: 14716961
[TBL] [Abstract][Full Text] [Related]
20. [The Pharmacia CAP system as a new measure of specific IgE. Application in the diagnosis of hypersensitivity to the venom of the Vespula wasp].
Sabbah A; Langlois P
Allerg Immunol (Paris); 1990 May; 22(5):173-8. PubMed ID: 2198045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
